Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair follicle pores help cell survival and growth, even after radiation.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Combining immune checkpoint inhibitors with other cancer therapies increases skin side effects in Asian patients.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Targeting colon cancer stem cells might lead to better treatment results.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Scalp cooling helps prevent hair loss during certain breast cancer treatments, especially when anthracyclines aren't used.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Managing inflammation and using vitamins can improve PRP therapy for better hair growth.